Eloxx Pharmaceuticals, Inc. Common Stock (ELOX)
Market Open
26 Oct, 06:37 PM
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
13. 22
+0.42
+3.2812%
$
45.08M Market Cap
- P/E Ratio
- Div Yield
24,481 Volume
0 Eps
$ 12.8
Previous Close Investors:
Want to track ELOX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) Statistics
Valuation metrics
Market Cap 45.08M
Enterprise value -17.98M
Trailing P/E (ttm) -8.42
Forward P/E -
PEG ratio -0.1
Price/Sales (ttm) -
Price/Book (mrq) 1.87
Enterprise Value/Revenue -
Enterprise Value/EBITDA 2.2
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 26.02K
Average volume (90 days) 38.09K
Price summary
52-Week low 8.2
52-Week high 23.4
Beta -
50-Day moving average 15.12
200-Day moving average 10.43
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:11
Last split Date 1 Jun 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.13%
Return on equity -0.43%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.22
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 9.13
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 3.74%
Book value per share (mrq) 6.84
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
